CGRP Targeted Therapies on the Horizon

(8:21)

An Update in Migraine Pathophysiology and CGRP Targeted Therapies - Grand Rounds SJHH

(59:53)

CGRP Targeted Therapies on the Horizon

(8:21)

Targeting CGRP for migraine prevention: the story so far

(2:4)

The future of migraine prevention with CGRP-targeted agents

(2:14)

The updated guidelines for treating migraines with CGRP-targeted monoclonal antibodies

(4:44)

Is the CGRP ligand or receptor a better target in migraine?

(2:52)

Targeting CGRP: Is it better to target the ligand or receptor in migraine prevention?

(2:1econd)

Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies

(18:18)

What exactly is CGRP? - Online interview

(3:23)

Latest guidelines on anti-CGRP antibodies: first-line and long-term use

(2:24)

CGRP-targeting tx are a 1st line option for migraine prevention: An AHS position statement update

(9:45)

Targeting CGRP: Improving Migraine Prevention

(2:53)

Blocking CGRP in migraine patients: cardiovascular implications

(2:9)

The Role of CGRP as Targeted Treatment for Migraine - Module 5: ALD403

(5:5)

Discontinuation of anti-CGRP antibodies in non-responders

(2:)

The role of CGRP in cluster headache

(3:34)

CGRP Inhibitors as Preventative Migraine Therapy

(4:25)

Targeting CGRP for the Prevention of Episodic Migraine

(6:58)

The Role of CGRP as Targeted Treatment for Migraine - Module 2: Ubrogepant

(5:46)